Intravitreal bevacizumab for the treatment of retinal neovascularization secondary to ocular toxoplasmosis.
Our aim was to present a case of ocular toxoplasmosis with retinal neovascularization treated with intravitreal bevacizumab. A 21-year-old healthy man had admitted to our Eye Clinic with complaints of floaters and blurred vision in the right eye (OD) for one year. On examination, visual acuity was 2...
| Publicado en: | Turkiye Klinikleri Journal of Medical Sciences Vol. 32; no. 2; pp. 529 - 532 |
|---|---|
| Autores principales: | , |
| Formato: | case study diagnostic images pictorial Journal Article |
| Publicado: |
Turkiye Klinikleri
Apr2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |